What is the medical insurance price of Erdafitinib? How much does the patient need to pay out of pocket after reimbursement?

Erdafitinib (Erdafitinib) is currently on the market in China, but since it has not yet been included in medical insurance, patients need to bear all costs when purchasing the drug in China. It is understood that the price of the original drug of erdafitinib is relatively high in the domestic market. Patients can purchase it at designated hospitals or pharmacies, but the specific selling price may fluctuate due to supply conditions. Since it is not included in the medical insurance catalog, patients are temporarily unable to enjoy the price discounts brought by medical insurance reimbursement, so the cost of purchasing drugs is relatively high.

For domestic patients, foreign channels may be another option to obtain erdafitinib. Currently, the original erdafitinib drug on the overseas market mainly comes from Hong Kong, China, and the price is usually more than 20,000 yuan. However, due to logistics, tariffs and other issues involved in imported drugs, the actual cost may be higher. In addition, some pharmacies or medical institutions in Hong Kong may provide drug purchase services, but patients must obtain them through legal and compliant channels to ensure drug quality.

In addition to original drugs, generic drugs are one of the feasible options for patients to reduce medication costs. Currently, there are generic drugs on the market such as the Lao version and the Bangladeshi Yaopin International version, with relatively low prices, usually ranging from a few hundred yuan to more than 2,000 yuan. The ingredients of these generic drugs are basically the same as those of the original drugs, but there may be certain differences in the efficacy of drugs produced by different manufacturers. Therefore, it is recommended that patients choose an appropriate drug purchase plan under the guidance of a doctor or pharmacist.

In the future, if erdafitinib can be included in the medical insurance catalog, patients' out-of-pocket expenses will be significantly reduced. Usually, after entering medical insurance, the reimbursement ratio of drugs may be between 50% and 70%, or even higher. The specific ratio needs to be determined according to local medical insurance policies. Therefore, patients can continue to pay attention to changes in medical insurance policies and consult local medical insurance departments or hospitals for the latest reimbursement status to obtain more economical treatment options.

Reference link:https://www.balversa.com/